Cell ther­a­py biotech Ser­no­va re­sponds to board nom­i­nees from 'con­cerned share­hold­er­s'

Cana­di­an cell ther­a­py biotech Ser­no­va is at­tempt­ing to clear the air on share­hold­er dis­sent.

Three can­di­dates are vy­ing for one board di­rec­tor seat, with two …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER